The Evil in Atherosclerosis: Adherent Platelets Induce Foam Cell Formation

 

 Buy Article Permissions and Reprints

ABSTRACT

Platelet interaction with circulating progenitor cells plays an important role for repair mechanisms at sites of vascular lesions. Foam cell formation represents a key process in atherosclerotic plaque formation. We revealed that platelets regulate recruitment and differentiation of CD34⁺ progenitor cells into foam cells and endothelial cells. Adhesion studies showed that platelets recruit CD34⁺ progenitor cells via specific adhesion receptors, including P-selection/P-selectin glycoprotein ligand 1, and β₁ and β₂ integrins. CD34⁺ progenitor cells were coincubated with human platelets for 1 week. We demonstrated that a substantial number of CD34⁺ cells differentiated into foam cells. Hydroxymethylglutaryl-coenzyme A reductase inhibitors (statins) and agonists of peroxisome proliferator-activated receptor-α and -γ (PPAR-α and -γ agonists) reduced this foam cell generation via inhibition of matrix metalloproteinase 9 secretions. Foam cell formation is also induced by low-density lipoproteins (LDLs). It was revealed that platelets take up modified LDL (fluorochrome-conjugated acetylated LDL) that is stored in the dense granules and internalized rapidly into the foam cells. These findings emphasize that the balance between endothelial cell regeneration and platelet-mediated foam cell generation derived from CD34⁺ progenitor cells may play a critical role in atherogenesis and atheroprogression.

REFERENCES

• 1 Aikawa M, Rabkin E, Sugiyama S et al.. An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro.  Circulation. 2001;  103(2) 276-283
  PubMedGoogle Scholar
• 2 Tsukamoto K, Kinoshita M, Kojima K et al.. Synergically increased expression of CD36, CLA-1 and CD68, but not of SR-A and LOX-1, with the progression to foam cells from macrophages.  J Atheroscler Thromb. 2002;  9(1) 57-64
  PubMedGoogle Scholar
• 3 Shashkin P, Dragulev B, Ley K. Macrophage differentiation to foam cells.  Curr Pharm Des. 2005;  11(23) 3061-3072
  CrossrefPubMedGoogle Scholar
• 4 Kunjathoor V V, Febbraio M, Podrez E A et al.. Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages.  J Biol Chem. 2002;  277(51) 49982-49988
  CrossrefPubMedGoogle Scholar
• 5 Geng Y J, Holm J, Nygren S, Bruzelius M, Stemme S, Hansson G K. Expression of the macrophage scavenger receptor in atheroma. Relationship to immune activation and the T-cell cytokine interferon-gamma.  Arterioscler Thromb Vasc Biol. 1995;  15(11) 1995-2002
  PubMedGoogle Scholar
• 6 Gough P J, Gordon S, Greaves D R. The use of human CD68 transcriptional regulatory sequences to direct high-level expression of class A scavenger receptor in macrophages in vitro and in vivo.  Immunology. 2001;  103(3) 351-361
  CrossrefPubMedGoogle Scholar
• 7 Holness C L, da Silva R P, Fawcett J, Gordon S, Simmons D L. Macrosialin, a mouse macrophage-restricted glycoprotein, is a member of the lamp/lgp family.  J Biol Chem. 1993;  268(13) 9661-9666
  PubMedGoogle Scholar
• 8 Pulford K A, Sipos A, Cordell J L, Stross W P, Mason D Y. Distribution of the CD68 macrophage/myeloid associated antigen.  Int Immunol. 1990;  2(10) 973-980
  CrossrefPubMedGoogle Scholar
• 9 Ramprasad M P, Terpstra V, Kondratenko N, Quehenberger O, Steinberg D. Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein.  Proc Natl Acad Sci USA. 1996;  93(25) 14833-14838
  CrossrefPubMedGoogle Scholar
• 10 Jans D M, Martinet W, Fillet M et al.. Effect of non-steroidal anti-inflammatory drugs on amyloid-beta formation and macrophage activation after platelet phagocytosis.  J Cardiovasc Pharmacol. 2004;  43(3) 462-470
  CrossrefPubMedGoogle Scholar
• 11 Relou I A, Hackeng C M, Akkerman J W, Malle E. Low-density lipoprotein and its effect on human blood platelets.  Cell Mol Life Sci. 2003;  60(5) 961-971
  PubMedGoogle Scholar
• 12 Chen M, Kakutani M, Naruko T et al.. Activation-dependent surface expression of LOX-1 in human platelets.  Biochem Biophys Res Commun. 2001;  282(1) 153-158
  CrossrefPubMedGoogle Scholar
• 13 Volf I, Moeslinger T, Cooper J, Schmid W, Koller E. Human platelets exclusively bind oxidized low density lipoprotein showing no specificity for acetylated low density lipoprotein.  FEBS Lett. 1999;  449(2-3) 141-145
  CrossrefPubMedGoogle Scholar
• 14 Schonbeck U, Libby P. Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents?.  Circulation. 2004;  109(21 suppl 1) II18-II26
  PubMedGoogle Scholar
• 15 Luan Z, Chase A J, Newby A C. Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages.  Arterioscler Thromb Vasc Biol. 2003;  23(5) 769-775
  PubMedGoogle Scholar
• 16 Puccetti L, Sawamura T, Pasqui A L, Pastorelli M, Auteri A, Bruni F. Atorvastatin reduces platelet-oxidized-LDL receptor expression in hypercholesterolaemic patients.  Eur J Clin Invest. 2005;  35(1) 47-51
  CrossrefPubMedGoogle Scholar
• 17 Bellosta S, Via D, Canavesi M et al.. HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages.  Arterioscler Thromb Vasc Biol. 1998;  18(11) 1671-1678
  PubMedGoogle Scholar
• 18 Galt S W, Lindemann S, Medd D et al.. Differential regulation of matrix metalloproteinase-9 by monocytes adherent to collagen and platelets.  Circ Res. 2001;  89(6) 509-516
  CrossrefPubMedGoogle Scholar
• 19 Abdelrahman M, Sivarajah A, Thiemermann C. Beneficial effects of PPAR-gamma ligands in ischemia-reperfusion injury, inflammation and shock.  Cardiovasc Res. 2005;  65(4) 772-781
  CrossrefPubMedGoogle Scholar
• 20 Shu H, Wong B, Zhou G et al.. Activation of PPARalpha or gamma reduces secretion of matrix metalloproteinase 9 but not interleukin 8 from human monocytic THP-1 cells.  Biochem Biophys Res Commun. 2000;  267(1) 345-349
  CrossrefPubMedGoogle Scholar
• 21 Chinetti G, Lestavel S, Bocher V et al.. PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway.  Nat Med. 2001;  7(1) 53-58
  PubMedGoogle Scholar
• 22 Chawla A, Barak Y, Nagy L, Liao D, Tontonoz P, Evans R M. PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation.  Nat Med. 2001;  7(1) 48-52
  PubMedGoogle Scholar

Meinrad GawazM.D. 

Medizinische Klinik III, Eberhard Karls Universität Tübingen

Otfried-Müller-Str. 10, D-72076 Tübingen, Germany

Email: meinrad.gawaz@med.uni-tuebingen.de